Protein Sciences wins FDA OK for egg-free Flublok
This article was originally published in Scrip
Protein Sciences’ long road to get to US FDA approval of the firm's novel influenza vaccine, which does not rely on chicken eggs but an insect virus, finally paid off on 16 January – with the win coming in the midst of a bad flu season that has struck most states across the nation.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.